Scientists are exploring leading-edge technologies that could transform how cancer is studied, detected and treated by ...

A new review by researchers at Oregon Health & Science University’s Knight Cancer Institute and other universities highlights how advances in New Approach Methodologies and tissue engineering are ...

Over the past generation, advances in treating common cancers—breast, lung, melanoma, and gastrointestinal (GI)—have improved ...

Doctors may be able to spare patients unnecessarily aggressive breast cancer treatments by collecting and testing cancer ...

University of Wisconsin’s Carbone Cancer Center recently announced a partnership with TAE Life Sciences, a company that ...

Researchers present an overview of treatment and management strategies for patients with HR+/HER2+ breast cancer, including common adverse effects.

Advances in systemic and local therapies are helping more live longer with liver cancer and move forward after treatment as ...

Agenus Inc. (($AGEN)) announced an update on their ongoing clinical study. A recent clinical study update from Agenus Inc. (AGEN) focuses on the ...

20 new anticancer therapeutics, two new devices, two minimally invasive tests, AI-based tools for early detection approved by FDA. (HealthDay News) — Progress in cancer research, including approval of ...

The study is testing INBRX-106, a hexavalent OX40 agonist antibody, designed to enhance the immune response against tumors. It is administered alone or with pembrolizumab, a well-known anti-PD-1 ...

Sellas Life Sciences Group Inc. (NASDAQ:SLS) is a biotechnology company that develops novel cancer therapies. Its lead ...